Constitutive and inducible expression and regulation of vascular endothelial growth factor.
Explore this paper's citation graph
Summary
In this review, molecular regulation of VEGF expression in tumor cells is discussed and the regulatory mechanisms of both inducible and constitutive V EGF expression will be crucial in designing effective therapeutic strategies targeting VEGf to control tumor growth and metastasis.
- Type
- article
- Published
- 2004-10-01
- Cited by
- 171
- References
- 345
- OpenAlex
- https://openalex.org/W15450248
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:8291635
Keywords
Computer science
References
- Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
- Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase.
- Neoangiogenesis and Relationship to Nuclear p53 Accumulation and Vascular Endothelial Growth Factor Expression in Advanced Gastric Carcinoma
- Role of nitric oxide in carcinogenesis and tumour progression.
- Vascular endothelial growth factor causally contributes to the angiogenic response upon ultraviolet B irradiation in vivo
- Antitumor effect of reduction of 150‐kDa oxygen‐regulated protein expression on human prostate cancer cells
- VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression.
- Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways1
- Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis.
- Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway.
- Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP.
- An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells
- Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer.
- Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element.
- Therapy of cancer metastasis by activation of the inducible nitric oxide synthase
- Demethylation by 5-aza-2'-deoxycytidine (5-azadC) of p16INK4A gene results in downregulation of vascular endothelial growth factor expression in human lung cancer cell lines.
- Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
- Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide.
- A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases.
- Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.
Cited by
- Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors.
- Reactive Oxygen Species as Signaling Molecules in Cardiovascular Differentiation of Embryonic Stem Cells and Tumor-Induced Angiogenesis
- Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells.
- Molecular treatment strategies and surgical reconstruction for metastatic bone diseases.
- Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis.
- The absorption of xanthohumol in in vitro and in vivo studies and the investigation of the biological activity of structurally related chalcones
- The Analysis of Vascular Endothelial Growth Factor Gene Polymorphisms on Clinical and Histopathology Features of Nasopharyngeal Carcinoma
- VEGFR3 and Notch signaling in angiogenesis
- TARGETED INHIBITION OF SP1 TRANSCRIPTION FACTOR AND ANTI-ANGIOGENESIS OF HUMAN PANCREATIC CANCER
- Cysteinyl‐leukotrienes induce vascular endothelial growth factor production in human monocytes and bronchial smooth muscle cells
- Role of gelatinases (matrix metalloproteinases 2 and 9), vascular endothelial growth factor and endostatin on clinicopathological behaviour of rectal cancer
- The potential of targeted antiangiogenesis therapies in the treatment of esophageal cancer
- The role of the systemic inflammatory response, the JAK STAT pathway and the MAPK pathway in the prognosis of resectable pancreatic cancer
- The role of AMP-activated protein kinase in endothelial VEGF signalling
- Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis.
- Angiogenic factors, bladder neuroplasticity and interstitial cystitis—new pathobiological insights
- Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy.
- Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma
- Double gene therapy with granulocyte colony-stimulating factor and vascular endothelial growth factor acts synergistically to improve nerve regeneration and functional outcome after sciatic nerve injury in mice.
- RAD51 as a potential biomarker and therapeutic target for pancreatic cancer.
Related papers
No related papers recorded.